New IOM president leaving Medtronic's board
February 21, 2014 by Arezu Sarvestani
Noted cardiologist and incoming Institute of Medicine president Dr. Victor Dzau is resigning from the board of directors for Medtronic (NYSE:MDT), effective 1 day before he starts his new job at the IOM.
Dzau has served on Medtronic’s board since 2008 and has been CEO of Duke University Health System since 2004. He’s leaving both behind to lead the IOM, an independent non-profit organization tasked with providing healthcare information and guidance to regulators. Dzau was elected to the IOM in 1998 and has "served on several leadership committees," the agency said. Read more
Hansen Medical CEO Barclay is out after Q4 slip to red
February 21, 2014 by Brad Perriello
Hansen Medical (NSDQ:HNSN) is looking for a new CEO to replace Bruce Barclay, who was let go after the robotic surgery company reported a slide to red ink for the 4th quarter.
Mountain View, Calif.-based Hansen said it named board member Christopher Lowe as interim CEO while it begins its search for Barclay’s permanent replacement. Read more
Bioheart CEO makes 1st public appearance since emergency cardiac surgery
February 24, 2014 by Arezu Sarvestani
Regenerative therapies maker Bioheart (PINK:BHRT) lauded the return of president & CEO Mike Tomas who underwent emergency open-heart surgery late last year.
Tomas, 47, was up and about, making his 1st post-surgery public appearance to moderate Florida International University’s Entrepreneurs in Tech panel. Bioheart offered few other details on Tomas’ condition or the cause of surgery. Read more
Medical device lobbies tap new government affairs execs
February 25, 2014 by Chris Walker
The Medical Device Manufacturers Assn. and the Medical Imaging Technology Alliance tapped a pair of Capitol Hill veterans to lead their government affairs departments.
Clayton Hall, a former chief of staff for 3 representatives with 12 years on The Hill, was named vice president of government affairs at MDMA, the association said. Read more
ConMed inks deal with investor, founder Corasanti to step down as chairman
February 26, 2014 by Brad Perriello
ConMed (NSDQ:CNMD) reached a deal with an institutional investor that owns a 6% stake in the medical device company that will see founder Eugene Corasanti step down as chairman, effective immediately.
Utica, N.Y.-based ConMed said the deal it struck with Coppersmith Capital Management calls for lead independent director Mark Tryniski to immediately succeed Corasanti, who founded the company in 1970 and led it until passing the reins to son Joseph Corasanti in 2006. Read more
